Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy

被引:17
作者
Kang, Yanlei [1 ]
Shao, Zhanying [2 ]
Wang, Qiang [1 ]
Hu, Xiurong [3 ]
Yu, Dongdong [4 ]
机构
[1] Zhejiang Univ, Dept Control Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China
[2] Zhejiang Ausun Pharmaceut Co Ltd, Taizhou 307016, Peoples R China
[3] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China
[4] Zhejiang Univ, Hosp Zhejiang Univ, Hangzhou 310027, Zhejiang, Peoples R China
关键词
Entecavir; Polymorphic impurity; Quantification; PXRD; Raman; DIFFERENTIAL SCANNING CALORIMETRY; ACTIVE-PHARMACEUTICAL-INGREDIENT; SIMULTANEOUS QUANTIFICATION; MULTIVARIATE CALIBRATION; INFRARED-SPECTROSCOPY; DIFFRACTION TECHNIQUE; DRUG SUBSTANCE; TABLETS; CRYSTALLINITY; FORMS;
D O I
10.1016/j.jpba.2018.05.026
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Entecavir was used for the treatment of chronic hepatitis B through inhibiting hepatitis B virus. The anhydrous form of entecavir (ENT-A) often appeared as impurity polymorph in the manufacturing process of entecavir monohydrate (ENT-H) such as granulation, drying and compression. Since different crystal forms might affect drug bioavailability and therapeutic effect, it was vital to control the ENT-A content of the drug product. The work aimed to develop useful methods to assess ENT-A weight percentage in ENT-H. Powder X-ray diffractometry (PXRD) and Raman spectrometric methods were applied. Binary mixtures with different ratios of pure ENT-H and pure ENT-A were scanned using PXRD and Raman to obtain spectra. Then peak heights and peak areas versus weight percentage were used to construct calibration curves. The best linear regression analysis data for PXRD and Raman method were found to be R-2 =0.9923 and R-2 =0.9953, in the weight ratio range of 2.1-20.2% w/w% of ENT-A in binary mixtures. Limit of detection (LOD)of ENT-A was 0.38% and limit of quantitation (LOQ) was 1.15% for PXRD method. LOD and LOQ for Raman method were 0.48% and 1.16%. The results showed that PXRD and Raman methods: both were precise and accurate, and could be used for measurement of ENT-A content in the selected weight percentage range. Partial least squares (PLS) algorithm with four data pre-processing methods: including multiplicative scatter correlation (MSC), standard normal variate (SNV), first and second derivatives were applied and evaluated using prediction errors. The best performance of PLS was R-2 = 0.9958 with RMSEC (0.44%) and RMSEP (0.65%). Multivariate analysis for Raman spectra showed similar good results with univariate analysis, and would be an advantageous method when there were overlapped peaks in the spectra. In summary, the proposed PXRD and Raman method could be developed for the quality control of ENT-H. And Raman was a more promising method in industrial practice due to its slightly better precision, accuracy and time-saving advantage. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:28 / 37
页数:10
相关论文
共 45 条
  • [41] Quantitative determination of polymorphic impurity by X-ray powder diffractometry in an OROS® formulation
    Varasteh, Mehdi
    Deng, Zhengyu
    Hwang, Helen
    Kim, Yoo Joong
    Wong, Geoffrey B.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 366 (1-2) : 74 - 81
  • [42] Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state 13C CPMAS NMR spectroscopy
    Virtanen, Tommi
    Maunu, Sirkka L.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 394 (1-2) : 18 - 25
  • [43] Quantitative determination of solid-state forms of a pharmaceutical development compound in drug substance and tablets
    Xie, Yong
    Tao, Wenle
    Morrison, Henry
    Chiu, Rick
    Jona, Janan
    Fang, Jan
    Cauchon, Nina
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 362 (1-2) : 29 - 36
  • [44] Ye W., 2008, CN patent, Patent No. [101245068 A, 101245068]
  • [45] Yi D., 2014, US patent, Patent No. [0220120 Al, 0020120]